TrialInternational journal of clinical oncology2017

Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.

Masanori Mori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.